Pura Vida Investments, LLC Chinook Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.63 - $27.35 $1.68 Million - $2.46 Million	90,000 New	90,000 $2.36 Million
Q2 2022 Aug 15, 2022	SELL	$12.59 - $18.8 $1.07 Million - $1.6 Million	-85,236 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$12.02 - $16.69 $60,160 - $83,533	-5,005 Reduced 5.55%	85,236 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$10.69 - $16.83 $187,534 - $295,248	17,543 Added 24.13%	90,241 $1.47 Million
Q3 2021 Nov 15, 2021	SELL	$11.5 - $14.86 $14,708 - $19,005	-1,279 Reduced 1.73%	72,698 $928,000
Q2 2021 Aug 16, 2021	BUY	$13.6 - $18.98 $1.01 Million - $1.4 Million	73,977 New	73,977 $1.05 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.